Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …

Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

